Stay updated on COTEZO IMblaze370 Clinical Trial
Sign up to get notified when there's something new on the COTEZO IMblaze370 Clinical Trial page.

Latest updates to the COTEZO IMblaze370 Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedAdded a government funding status notice and a new version tag (v3.2.0); removed the old version tag (v3.1.0).SummaryDifference2% 
- Check33 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no substantive content changes detected.SummaryDifference0.0% 
- Check48 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2; the 'Back to Top' link was removed.SummaryDifference0.1% 
- Check55 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.1% 
- Check62 days agoChange DetectedThe webpage has undergone significant updates, including the addition of new facility names and locations, particularly in South Korea, Russia, and Italy, as well as the inclusion of relevant medical topics related to colorectal cancer. Notably, the term 'regorafenib' has been removed, which may impact the context of cancer treatment discussions.SummaryDifference15% 
- Check76 days agoChange DetectedThe web page has been updated from version v2.16.11 to v2.16.12.SummaryDifference0.0% 
Stay in the know with updates to COTEZO IMblaze370 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the COTEZO IMblaze370 Clinical Trial page.